Tag: GLP-1 market

Market News

Eli Lilly Q1 2026 Earnings Surge on Zepbound Mounjaro Demand

Eli Lilly just posted mind-blowing Q1 results driven by its blockbuster weight loss and diabetes drugs. Revenue up 56%, guidance...

03/05/2026

6 views

Read More

Market News

Eli Lilly Stock Slides on Bearish GLP-1 Outlook: Our Take

Eli Lilly's stock just took a 6% hit after analysts warned the GLP-1 obesity market might be overhyped—with smaller size...

19/03/2026

4 views

Read More

Market News

FDA Flags Misleading Claims in Obesity Pill TV Ad

The FDA just hit a blockbuster obesity pill's TV ad with a serious warning over misleading claims that promise more...

10/02/2026

4 views

Read More

Market News

Eli Lilly Crushes Q4 2025 Earnings With Massive Zepbound Boost

Eli Lilly just dropped their Q4 2025 earnings, and the numbers are staggering – revenue way above expectations thanks to...

04/02/2026

7 views

Read More

Altcoins

Eli Lilly’s $3.5 Billion Bet on Next-Gen Obesity Drugs

Eli Lilly just committed $3.5 billion to a massive new plant in Pennsylvania focused on next-generation obesity drugs, including one...

30/01/2026

2 views

Read More

Global Companies

Eli Lilly Bets $6 Billion on Alabama Plant for Obesity Drugs

Eli Lilly just dropped $6 billion on a massive new plant in Alabama — and the main reason is one...

09/12/2025

8 views

Read More

Global Companies

Pfizer Bets Big on Oral Obesity Pill in $2.1B China Deal

Pfizer just dropped $150M upfront (and up to $2.1B total) on a Chinese company's oral obesity pill. After losing the...

09/12/2025

8 views

Read More

Global Markets

Weight Loss Drugs Future: Pills, Rivals, Insurance

The weight loss drug arena is exploding toward a $100 billion future, with pills on the horizon and rivals closing...

02/11/2025

6 views

Read More

Market News

Pfizer’s Big Bet on Obesity Drugs: Why Stocks Soared

Pfizer’s $7B move to dominate obesity drugs sent its stock soaring. But what makes this deal a game-changer for investors?...

22/09/2025

5 views

Read More

Market News

Why Lilly’s Obesity Pill Miss Shook Investors

Lilly's stock crashed after its obesity pill trial fell short. What went wrong, and what’s next for the weight-loss drug...

07/08/2025

5 views

Read More